Overcoming physical stromal barriers to cancer immunotherapy

被引：0
作者：
Seung Woo Chung
Yunxuan Xie
Jung Soo Suk
机构：
[1] The Johns Hopkins University School of Medicine,Center for Nanomedicine
[2] The Johns Hopkins University School of Medicine,Department of Ophthalmology
[3] The Johns Hopkins University,Department of Chemical and Biomolecular Engineering
来源：
Drug Delivery and Translational Research | 2021年 / 11卷
关键词：
Tumor endothelium; Extracellular matrix; Tumor microenvironment; Tumor infiltration; Combination regimen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2430 / 2447
页数：17
相关论文
共 1029 条
  • [1] Quesada JR(2013)Cancer immunotherapy Science 342 1432-1433
  • [2] Hersh EM(1986)Treatment of hairy cell leukemia with recombinant alpha-interferon Blood 68 493-497
  • [3] Manning J(1999)High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993 J Clin Oncol 17 2105-2116
  • [4] Reuben J(2020)The future of cancer immunotherapy: microenvironment-targeting combinations Cell Res 30 507-519
  • [5] Keating M(2011)Cancer immunotherapy comes of age Nature 480 480-489
  • [6] Schnipper E(2018)Cancer immunotherapy using checkpoint blockade Science 359 1350-1355
  • [7] Itri L(2018)Trial watch: the clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors Nat Rev Drug Discov 17 854-855
  • [8] Gutterman JU(2018)Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges Nat Rev Clin Oncol 15 325-340
  • [9] Atkins MB(2015)Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy Eur J Pharm Biopharm 93 52-79
  • [10] Lotze MT(2018)Molecular targeted therapy: treating cancer with specificity Eur J Pharmacol 834 188-196
12345678910